A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Active, not recruiting · NCT05804669 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome | ACTH-dependent Cushing syndrome, Cushing syndrome, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, central nervous system disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hyperpituitarism, hypothalamic disorder, neoplasm, nervous system disorder, paraneoplastic syndrome, pituitary gland disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT05804669 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Crinetics Pharmaceuticals Inc. | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Bethesda | United States | 1 |